Cargando…
Eligibility for Human Leukocyte Antigen–Based Therapeutics by Race and Ethnicity
IMPORTANCE: The development of therapeutics for patients who are positive for specific human leukocyte antigen (HLA) subtypes evokes the question of whether certain racial and ethnic groups are more or less likely to be eligible for novel products. OBJECTIVE: To determine whether racial and ethnic i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603498/ https://www.ncbi.nlm.nih.gov/pubmed/37883087 http://dx.doi.org/10.1001/jamanetworkopen.2023.38612 |